Duramed Announces Time Change for First Quarter Conference Call

Apr 25, 2001, 01:00 ET from Duramed Pharmaceuticals, Inc.

    CINCINNATI, April 25 /PRNewswire/ -- Duramed Pharmaceuticals, Inc.
 (Nasdaq: DRMD) announced today that its first quarter 2001 conference call on
 May 2, 2001, has been changed from 10:00 A.M. EST to 8:45 A.M. EST.  The web
 cast, which can be accessed at http://www.videonewswire.com/DURAMED/050201/,
 will also begin at 8:45 A.M. EST.
 
     About the Company
     Duramed Pharmaceuticals, Inc. develops, manufactures and markets
 prescription drug products.  The company's business strategy emphasizes
 products with attractive market opportunities and potentially limited
 competition due to technological barriers to entry, focusing on women's health
 and the hormone replacement therapy market.  The company's mission is to be
 the premier supplier of solid oral dose hormone products.
     Duramed's containment manufacturing facility for the production of
 hormones distinguishes the company from most competitors.  The facility
 incorporates enclosed product flow and state-of-the-art environmental controls
 to ensure purity, stability, and tablet uniformity for its hormone products.
     The company's stock is traded on Nasdaq using the symbol DRMD.  Additional
 information about the company can be found on the World Wide Web at
 www.duramed.com and www.cenestin.com .
     If you are unable to participate during the live web cast, the call will
 be archived on the Web site www.duramed.com/investors .  To access the replay,
 click on the web cast logo.  Minimum Requirements to listen to broadcast: The
 RealPlayer software, downloadable free from
 www.real.com/products/player/index.html , and at least a 14.4Kbps connection
 to the Internet.  If you experience problems listening to the broadcast, send
 an email to webmaster@vdat.com .
 
                        MAKE YOUR OPINION COUNT - Click Here
                  http://tbutton.prnewswire.com/prn/11690X01851191
 
 

SOURCE Duramed Pharmaceuticals, Inc.
    CINCINNATI, April 25 /PRNewswire/ -- Duramed Pharmaceuticals, Inc.
 (Nasdaq: DRMD) announced today that its first quarter 2001 conference call on
 May 2, 2001, has been changed from 10:00 A.M. EST to 8:45 A.M. EST.  The web
 cast, which can be accessed at http://www.videonewswire.com/DURAMED/050201/,
 will also begin at 8:45 A.M. EST.
 
     About the Company
     Duramed Pharmaceuticals, Inc. develops, manufactures and markets
 prescription drug products.  The company's business strategy emphasizes
 products with attractive market opportunities and potentially limited
 competition due to technological barriers to entry, focusing on women's health
 and the hormone replacement therapy market.  The company's mission is to be
 the premier supplier of solid oral dose hormone products.
     Duramed's containment manufacturing facility for the production of
 hormones distinguishes the company from most competitors.  The facility
 incorporates enclosed product flow and state-of-the-art environmental controls
 to ensure purity, stability, and tablet uniformity for its hormone products.
     The company's stock is traded on Nasdaq using the symbol DRMD.  Additional
 information about the company can be found on the World Wide Web at
 www.duramed.com and www.cenestin.com .
     If you are unable to participate during the live web cast, the call will
 be archived on the Web site www.duramed.com/investors .  To access the replay,
 click on the web cast logo.  Minimum Requirements to listen to broadcast: The
 RealPlayer software, downloadable free from
 www.real.com/products/player/index.html , and at least a 14.4Kbps connection
 to the Internet.  If you experience problems listening to the broadcast, send
 an email to webmaster@vdat.com .
 
                        MAKE YOUR OPINION COUNT - Click Here
                  http://tbutton.prnewswire.com/prn/11690X01851191
 
 SOURCE  Duramed Pharmaceuticals, Inc.